+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, Distribution Channel - Global Forecast to 2030- Product Image
mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, Distribution Channel - Global Forecast to 2030- Product Image
Sale

mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055092
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mRNA vaccines market is undergoing significant transformation as advances in messenger RNA technology redefine how disease prevention and treatment strategies are developed. Senior decision-makers must closely monitor these trends to ensure timely, strategic positioning within this dynamic sector.

Market Snapshot: mRNA Vaccines Market Overview

The global mRNA vaccines market was valued at USD 9.32 billion in 2024 and is projected to reach USD 10.40 billion in 2025, with a compound annual growth rate (CAGR) of 11.86%, ultimately expected to achieve USD 18.28 billion by 2030. This strong growth trajectory is driven by the broadening application of messenger RNA vaccine platforms in both preventive and therapeutic healthcare, notable advancements in delivery technologies, and ongoing global investment in mRNA innovation.

Scope & Segmentation

This research evaluates the mRNA vaccines market across several critical dimensions:

  • Technology Types: Lipid nanoparticle platforms, nucleoside-modified mRNA solutions, self-amplifying mRNA systems
  • Routes of Administration: Inhalable mRNA vaccines, injectable vaccines, oral delivery methods
  • Manufacturing Processes: Cell-free synthesis, in vitro transcription workflows
  • Vaccine Classifications: Preventive, therapeutic
  • Application Areas: Cardiovascular disorders, genetic disorders (including cystic fibrosis and sickle cell disease), infectious diseases (such as COVID-19 and influenza), oncology
  • Distribution Channels: Hospital pharmacies, retail pharmacies
  • Regions Covered: Americas (including United States, Canada, Brazil, and others), Europe, Middle East & Africa (including key European Union states, Gulf nations, and African hubs), Asia-Pacific (China, Japan, India, Southeast Asian countries, Australia)
  • Company Coverage: Leading organizations such as Moderna, BioNTech, CureVac, Arcturus Therapeutics Holdings, AstraZeneca, Pfizer, and additional prominent market participants

Key Takeaways for Senior Decision-Makers

  • mRNA vaccines have evolved beyond pandemic response and now form the backbone of emerging solutions for oncology and rare genetic conditions, supported by broad investment and policy momentum.
  • Ongoing improvements in lipid nanoparticle design and self-amplifying platforms are optimizing both delivery efficiency and durability, minimizing resource requirements and enhancing patient outcomes.
  • As regulatory authorities introduce adaptive review and collaboration workflows, organizations with streamlined development and manufacturing pipelines can reduce time to market for next-generation candidates.
  • Supply chain realignments, prompted by changes such as recent tariffs and shifting global input sourcing, are compelling manufacturers to rethink regional production strategies and prioritize resilience.
  • Heightened partnerships between biopharmaceutical companies, contract manufacturers, and research institutions are expanding commercial access and accelerating pipeline diversification across new therapeutic categories.

Tariff Impact: Navigating Regulatory Changes

The upcoming 2025 US tariff adjustments on imported raw materials and finished mRNA vaccines are expected to influence production costs and supply chain strategies. While larger integrated vaccine developers have the capacity to absorb or redistribute increased costs, smaller biotechnology firms are more vulnerable to these pricing pressures. The market is seeing an increased push for localized production infrastructure and strategic partnerships to mitigate tariff effects, foster supply reliability, and maintain long-term competitiveness.

Methodology & Data Sources

This report is underpinned by a blend of primary expert interviews and secondary evaluations, including regulatory reviews, corporate disclosures, technical literature, and patent analyses. Cross-functional data validation and scenario planning have been applied to ensure all findings are comprehensive, consistent, and actionable for strategic planning within the mRNA vaccines market.

Why This Report Matters

  • Provides actionable insights for investment prioritization across technology, geography, and therapeutic focus areas in the rapidly evolving mRNA vaccines market.
  • Enables organizational leaders to identify supply chain vulnerabilities and opportunities for differentiation in the face of regulatory and geopolitical shifts.
  • Supports commercial and scientific teams in benchmarking organizational positioning against innovation, regulatory alignment, and clinical pipeline advancement globally.

Conclusion

The mRNA vaccines market is experiencing rapid evolution, driven by technology innovation, regulatory adaptation, and geographic diversification. Organizations that act on these insights, cultivating supply chain resilience and advancing differentiated pipelines, are best placed to achieve sustainable growth and impact in the mRNA vaccine landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. mRNA Vaccines Market, by Technology Type
8.1. Introduction
8.2. Lipid Nanoparticle (LNP) Platforms
8.3. Nucleoside-Modified mRNA Technologies
8.4. Self-Amplifying mRNA Platforms
9. mRNA Vaccines Market, by Route of Administration
9.1. Introduction
9.2. Inhalable mRNA Vaccines
9.3. Injectable mRNA Vaccines
9.4. Oral Delivery System
10. mRNA Vaccines Market, by Manufacturing Process
10.1. Introduction
10.2. Cell-Free Synthesis
10.3. In Vitro Transcription
11. mRNA Vaccines Market, by Vaccine Classification
11.1. Introduction
11.2. Preventive Vaccines
11.3. Therapeutic Vaccines
12. mRNA Vaccines Market, by Application Areas
12.1. Introduction
12.2. Cardiovascular Disorders
12.3. Genetic Disorders
12.3.1. Cystic Fibrosis Treatments
12.3.2. Sickle Cell Disease mRNA Approaches
12.4. Infectious Diseases
12.4.1. COVID-19 Vaccines
12.4.2. Influenza mRNA Vaccines
12.5. Oncology
13. mRNA Vaccines Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Retail Pharmacies
14. Americas mRNA Vaccines Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa mRNA Vaccines Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific mRNA Vaccines Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Acuitas Therapeutics Inc.
17.3.2. Alnylam Pharmaceuticals, Inc.
17.3.3. Arcturus Therapeutics Holdings Inc.
17.3.4. AstraZeneca PLC
17.3.5. Bavarian Nordic AS
17.3.6. BioNTech SE
17.3.7. Chongqing Zhifei Biological Products Co.,Ltd.
17.3.8. CureVac N.V.
17.3.9. Daiichi Sankyo Company, Limited
17.3.10. Eli Lilly and Company
17.3.11. Ethris GmbH
17.3.12. GlaxoSmithKline PLC
17.3.13. Inovio Pharmaceuticals, Inc.
17.3.14. Johnson & Johnson Services, Inc.
17.3.15. Merck & Co., Inc.
17.3.16. Moderna Inc.
17.3.17. Novartis AG
17.3.18. Pfizer Inc.
17.3.19. Regeneron Pharmaceuticals, Inc.
17.3.20. Roche Holding AG
17.3.21. Sanofi S.A.
17.3.22. Sinovac Biotech Ltd.
17.3.23. Takeda Pharmaceutical Company Limited
17.3.24. Thermo Fisher Scientific Inc.
17.3.25. Vertex Pharmaceuticals Incorporated
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. MRNA VACCINES MARKET MULTI-CURRENCY
FIGURE 2. MRNA VACCINES MARKET MULTI-LANGUAGE
FIGURE 3. MRNA VACCINES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MRNA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MRNA VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MRNA VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MRNA VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MRNA VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MRNA VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MRNA VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MRNA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MRNA VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MRNA VACCINES MARKET SIZE, BY LIPID NANOPARTICLE (LNP) PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MRNA VACCINES MARKET SIZE, BY NUCLEOSIDE-MODIFIED MRNA TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MRNA VACCINES MARKET SIZE, BY SELF-AMPLIFYING MRNA PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MRNA VACCINES MARKET SIZE, BY INHALABLE MRNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MRNA VACCINES MARKET SIZE, BY INJECTABLE MRNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MRNA VACCINES MARKET SIZE, BY ORAL DELIVERY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MRNA VACCINES MARKET SIZE, BY CELL-FREE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MRNA VACCINES MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MRNA VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MRNA VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MRNA VACCINES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MRNA VACCINES MARKET SIZE, BY CYSTIC FIBROSIS TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MRNA VACCINES MARKET SIZE, BY SICKLE CELL DISEASE MRNA APPROACHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MRNA VACCINES MARKET SIZE, BY COVID-19 VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MRNA VACCINES MARKET SIZE, BY INFLUENZA MRNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MRNA VACCINES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MRNA VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MRNA VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES MRNA VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 55. CANADA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 57. CANADA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 58. CANADA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 59. CANADA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. GERMANY MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. GERMANY MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 104. GERMANY MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 105. GERMANY MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 106. GERMANY MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 107. GERMANY MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 108. GERMANY MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. FRANCE MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 110. FRANCE MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. FRANCE MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 112. FRANCE MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 113. FRANCE MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 114. FRANCE MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 115. FRANCE MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 116. FRANCE MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ITALY MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 126. ITALY MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. ITALY MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 128. ITALY MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 130. ITALY MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 131. ITALY MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 132. ITALY MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SPAIN MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. SPAIN MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 136. SPAIN MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 137. SPAIN MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 138. SPAIN MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 139. SPAIN MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 140. SPAIN MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. DENMARK MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 166. DENMARK MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. DENMARK MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 168. DENMARK MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 169. DENMARK MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 170. DENMARK MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 171. DENMARK MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 172. DENMARK MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. QATAR MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 182. QATAR MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. QATAR MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 184. QATAR MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 185. QATAR MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 186. QATAR MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 187. QATAR MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 188. QATAR MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. FINLAND MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. FINLAND MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 192. FINLAND MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 193. FINLAND MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 194. FINLAND MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 196. FINLAND MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. EGYPT MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. EGYPT MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 216. EGYPT MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 217. EGYPT MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 218. EGYPT MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 220. EGYPT MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. TURKEY MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. TURKEY MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 228. TURKEY MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. NORWAY MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 238. NORWAY MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. NORWAY MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 240. NORWAY MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 241. NORWAY MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 242. NORWAY MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. POLAND MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 246. POLAND MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. POLAND MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 248. POLAND MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 249. POLAND MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 250. POLAND MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 251. POLAND MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 252. POLAND MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 270. CHINA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 271. CHINA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. CHINA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 273. CHINA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 274. CHINA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 275. CHINA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 276. CHINA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 277. CHINA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. INDIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. INDIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 281. INDIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 282. INDIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 283. INDIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 284. INDIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 285. INDIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. JAPAN MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 287. JAPAN MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 288. JAPAN MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 289. JAPAN MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 290. JAPAN MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 291. JAPAN MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 292. JAPAN MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 293. JAPAN MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. THAILAND MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 319. THAILAND MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 320. THAILAND MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 321. THAILAND MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 322. THAILAND MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 323. THAILAND MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 324. THAILAND MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 325. THAILAND MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE MRN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this mRNA Vaccines market report include:
  • Acuitas Therapeutics Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Arcturus Therapeutics Holdings Inc.
  • AstraZeneca PLC
  • Bavarian Nordic AS
  • BioNTech SE
  • Chongqing Zhifei Biological Products Co.,Ltd.
  • CureVac N.V.
  • Daiichi Sankyo Company, Limited
  • Eli Lilly and Company
  • Ethris GmbH
  • GlaxoSmithKline PLC
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Moderna Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
  • Vertex Pharmaceuticals Incorporated

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.28 Billion
Compound Annual Growth Rate11.8%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions - Product Image

mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions

  • Report
  • 343 Pages
  • Global
From
mRNA Vaccines and Therapeutics Market Report by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-User, and Region 2025-2033 - Product Image

mRNA Vaccines and Therapeutics Market Report by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-User, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
mRNA Vaccine and Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

mRNA Vaccine and Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
mRNA Vaccines and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

mRNA Vaccines and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 159 Pages
  • Global
From
Self Amplifying RNA Vaccines Patent Landscape Report and Forecast 2024-2032 - Product Image

Self Amplifying RNA Vaccines Patent Landscape Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From

About the mRNA Vaccines Market

In the landscape of vaccines, mRNA (messenger RNA) vaccines represent a novel technology that has garnered substantial attention for its role in rapid vaccine development. These vaccines operate by instructing cells to produce a protein that triggers an immune response without using a live virus. This innovative approach stands out for its ability to be developed and scaled up swiftly in response to infectious diseases, offering a flexible platform for vaccine creation. While traditional vaccine development may take years of research and testing, mRNA vaccines can be designed once the genetic information of a pathogen is known. The adoption of mRNA vaccines has been driven by their potential to address a broad spectrum of diseases beyond just infectious agents. Research is being conducted into their applicability in treating and preventing cancers, genetic disorders, and autoimmune diseases. This expansion of mRNA technology into various medical domains has contributed to the diversification of the vaccine industry. Several prominent companies are active in the mRNA vaccines market, shaping its trajectory with their research and development efforts. Notable firms include Moderna, Pfizer in collaboration with BioNTech, and CureVac. These companies have invested heavily in mRNA technology, leading to advances that have solidified their positions as key players in the pharmaceutical and biotechnology sectors. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.